Goldman Sachs’s ThermoGenesis Holdings, Inc. Common Stock THMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-1,106
Closed -$134K 6593
2021
Q1
$134K Buy
1,106
+571
+107% +$74.3K ﹤0.01% 5767
2020
Q4
$50K Buy
+535
New +$57.2K ﹤0.01% 5383
2016
Q1
Sell
-2
Closed -$3K 7368
2015
Q4
$3K Sell
2
-1
-33% -$4.07K ﹤0.01% 7071
2015
Q3
$16K Sell
3
-1
-25% -$6.09K ﹤0.01% 7079
2015
Q2
$31K Sell
4
-1
-20% -$7.85K ﹤0.01% 6997
2015
Q1
$39K Sell
5
-2
-29% -$16.8K ﹤0.01% 6769
2014
Q4
$60K Buy
7
+2
+40% +$19.8K ﹤0.01% 6754
2014
Q3
$55K Buy
+5
New +$60.2K ﹤0.01% 6787

Other funds holding THMO

Goldman Sachs's THMO Position: Q2 2021 in Review

Goldman Sachs sold out of ThermoGenesis Holdings, Inc. Common Stock (THMO) in Q2 2021, closing a stake of 1,106 shares — an estimated $134K sold.

Goldman Sachs first reported a position in THMO in Q3 2014 and held it in 8 quarters. The position peaked at $134K in Q1 2021. 16 funds tracked by Wall St. Rank hold THMO as of Q2 2021.

  • Goldman Sachs reported no remaining ThermoGenesis Holdings, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Goldman Sachs sold 1,106 ThermoGenesis Holdings, Inc. Common Stock shares in Q2 2021, an estimated $134K.
  • Goldman Sachs first reported a position in ThermoGenesis Holdings, Inc. Common Stock in Q3 2014 and held it in 8 quarters.
  • Goldman Sachs's ThermoGenesis Holdings, Inc. Common Stock position peaked at $134K in Q1 2021.
  • 16 funds tracked by Wall St. Rank held ThermoGenesis Holdings, Inc. Common Stock as of Q2 2021.

Based on Goldman Sachs's 13F filing for Q2 2021, filed 13 Aug 2021.